Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants

BACKGROUND: Development of in vivo biomarkers has shifted the diagnosis of Alzheimer’s disease (AD) from the later dementia stages of disease towards the earlier stages and has introduced the potential for pre-symptomatic diagnosis. The International Working Group recommends that AD diagnosis is res...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubois, Bruno, von Arnim, Christine A. F., Burnie, Nerida, Bozeat, Sasha, Cummings, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571241/
https://www.ncbi.nlm.nih.gov/pubmed/37833762
http://dx.doi.org/10.1186/s13195-023-01314-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571241/
https://www.ncbi.nlm.nih.gov/pubmed/37833762
http://dx.doi.org/10.1186/s13195-023-01314-6

Ejemplares similares